Research ExplorerPublicationsAn anti-OX40 antibody to treat moderate-to-severe atopic der... Publications

An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis:a multicentre, double-blind, placebo-controlled phase 2b study

1 - 1 out of 1Page size: 50

Publications

  1. 2023

  2. Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis - Authors' reply

    Guttman-Yassky, E., Simpson, E. L., Reich, K., Kabashima, K., Igawa, K., Suzuki, T., Mano, H., Matsui, T., Esfandiari, E. & Furue, M., 18.11.2023, In: LANCET. 402, 10415, p. 1834

    Research output: SCORING: Contribution to journal › Comment/debate › Research